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http://dx.doi.org/10.1016/j.jacl.2016.09BACKGROUND: Current dietary guidelines recommend the replacement of saturated fatty acids
(SAFAs) with carbohydrates or monounsaturated fatty acids (MUFAs) based on evidence on lipid pro-
file alone, the chronic effects of the mentioned replacements on insulin secretion and insulin sensitivity
are however unclear.
OBJECTIVE: To assess the chronic effects of the substitution of refined carbohydrate or MUFA for
SAFA on insulin secretion and insulin sensitivity in centrally obese subjects.
METHODS: Using a crossover design, randomized controlled trial in abdominally overweight men
and women, we compared the effects of substitution of 7% energy as carbohydrate or MUFA for SAFA
for a period of 6 weeks each. Fasting and postprandial blood samples in response to corresponding
SAFA, carbohydrate, or MUFA-enriched meal-challenges were collected after 6 weeks on each diet
treatment for the assessment of outcomes.
RESULTS: As expected, postprandial nonesterified fatty acid suppression and elevation of C-pep-
tide, insulin and glucose secretion were the greatest with high-carbohydrate (CARB) meal. Interest-
ingly, CARB meal attenuated postprandial insulin secretion corrected for glucose response;
however, the insulin sensitivity and disposition index were not affected. SAFA and MUFA had similar
effects on all markers except for fasting glucose-dependent insulinotropic peptide concentrations,
which increased after MUFA but not SAFA when compared with CARB.
CONCLUSION: In conclusion, a 6-week lower-fat/higher-carbohydrate (increased by 7% refined
carbohydrate) diet may have greater adverse effect on insulin secretion corrected for glucose comparedIdentifier NCT01665482.
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1432 Journal of Clinical Lipidology, Vol 10, No 6, December 2016with isocaloric higher-fat diets. In contrast, exchanging MUFA for SAFA at 7% energy had no appre-
ciable adverse impact on insulin secretion.
 2016 National Lipid Association. Published by Elsevier Inc. This is an open access article under the CC
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Central obesity, a component of the metabolic syn-
drome, is closely linked to insulin resistance and predis-
posed to the development of type 2 diabetes. The role of
defective insulin secretion in the pathogenesis of type 2
diabetes, however, has received less attention. The high-
fasting insulin concentration in type 2 diabetes patients in
fact resembles insulin deficit rather than hyperinsulinemia
under the condition of concurrently elevated glucose con-
centration.1 Emerging evidence showed that decline of
glucose tolerance may be elicited by the insulin secretory
defect rather than by obesity itself.2 WHO recommends a
reduction in saturated fats to ,10% energy (en) with the
replacement of carbohydrate or monounsaturated fats, for
CHD prevention.3 A recent meta-analysis of observational
studies does not support the association of aforementioned
replacement of saturated fats with reduction in diabetes risk
in healthy individuals.4 Conflicting findings were reported
by three large scale interventional studies5–7 (to be dis-
cussed in Discussion part).
Gastrointestinal peptides such as glucagon-like peptides
(GLP-1), glucose-dependent insulinotropic polypeptide
(GIP), ghrelin, peptide YY (PYY), and cholecystokinin
(CCK) are short-term signals for satiety feedback to the
brain and hence play a role in regulating glucose homeosta-
sis.8,9 For example, lipid-induced CCK release was found to
inhibit hepatic glucose production, and high-fat overfeeding
was found to impair the gut-brain-liver neuronal mechanism
hence leading to hyperglycemia.10 There is growing clinical
evidence that the levels of gastrointestinal peptides are
compromised in overweight individuals,11 impaired glucose
tolerance,12 and type 2 diabetes patients.13,14 Thomsen et al.
reported that the ingestion of monounsaturated fat-enriched
(MUFA) meal resulted in a higher GIP15 and GLP-116 con-
centrations compared with a saturated fat-enriched (SAFA)
meal in both overweight with type 2 diabetes and lean,
healthy subjects. In this context, the type of dietary fats, in
particular triglycerides with different fatty acid chain lengths
or degree of saturation may exert a differential impact on in-
cretins, that is, GIP and GLP-1, which play an important role
in insulin secretion.
Owing to the limited and conflicting data available on the
aforementioned, the present study was designed to investi-
gate the fasting and postprandial effects of the replacement
of 7% en SAFA with carbohydrate or MUFA on insulin
secretion, insulin sensitivity, glucose homeostasis, and
gastrointestinal peptide responses in individuals with centralobesity. A 7% en exchange of specific nutrients applied in
this study was intended to reflect the practical scenario of the
reduction of total SAFA intake. The current dietary guideline
recommended by World Health Organization (WHO) is a
,10% en intake of total SAFA. In addition, we also
performed metabolic challenge test, which reflected a single
meal habitual dietary intake at the end of each dietary
intervention. Such setting was important as postprandial
lipemia and postprandial glycemia after each dietary pattern
have been indicated in the etiology of chronic metabolic
diseases such as T2DM and CVD.Materials and methods
Participants
The study protocol was approved by the Medical Ethics
Committee of University of Malaya Medical Centre
(reference no. 871.5). Participants gave informed written
consent and attended a screening clinic. Fifty-four men and
women aged 20–60 years with waist circumference
$80 cm (for women) and $90 cm (for men) were
recruited. Exclusion criteria were BMI # 18.5 kg/m2; med-
ical history of CVD, diabetes, dyslipidemia; diagnosed
chronic illness; current use of antihypertensive or lipid-
lowering medication; plasma total cholesterol
.6.5 mmol/L, triacylglycerol .4.5 mmol/L; alcohol intake
.28 units/week; and lactating, pregnancy, and smoking.
The flow of subject recruitment is shown in the CONSORT
diagram (Fig. 1). Subjects’ baseline characteristics are
shown in Table 1.
Experimental design
This was a randomized, controlled, single-blind, crossover
trial under free-living conditions. The study design is outlined
in Figure 2. The study intervention was carried out from early
March through mid-July 2012 at the Malaysian Palm Oil
Board, Malaysia. Subjects were assigned to 3 consecutive
6-week isocaloric diets (w2000 kcal/day): SAFA (control;
55% carbohydrate, 32% fat: 12% saturated fat, 13%
monounsaturated fat), carbohydrate-enriched (CARB; 62%
carbohydrate, 25% fat: 5% SAFA, 14% MUFA) or
MUFA (55% carbohydrate, 32% fat: 5% SAFA, 20%
MUFA) in random order using an orthogonal randomization
allocation (treatment sequences in SAFA-MUFA-CARB,
MUFA-CARB-SAFA, and CARB-SAFA-MUFA). Women
Figure 1 Consort diagram.
Table 1 Baseline characteristics of the study participants
completing the 3 x 6-week dietary interventions
Variables All*
Physical characteristics
Age (y) 32.8 6 8.7
Gender
Female (n) 35
Male (n) 12
Metabolic syndrome (n) 16
Overweight (n)‡ 18
Obese (n)‡ 27
Height (m) 159.4 6 7.8
Weight (kg) 74.2 6 14.6
BMI (kg/m2) 28.7 6 4.1
Waist circumference (cm) 94.8 6 10.2
Body fat (%) 36.6 6 7.9
Systolic BP (mm Hg) 124.5 6 12.4
Diastolic BP (mm Hg) 81.8 6 10.7
Biochemical profile
Serum C-peptide (nmol/L) 0.6 6 0.3
Serum insulin (mU/L) 16.5 6 10.3
Plasma glucose (mmol/L) 5.8 6 0.8
Serum total cholesterol (mmol/L) 5.0 6 0.8
Serum HDL cholesterol (mmol/L) 1.3 6 0.3
Serum LDL cholesterol (mmol/L) 3.1 6 0.7
Serum TAG (mmol/L) 1.2 6 0.7
Total: HDL cholesterol 4.0 6 0.8
Serum NEFA (mmol/L) 0.7 6 0.2
Dietary intake†
Energy (kcal/d) 2051.8 6 545.3
Protein (% en) 16.3 6 2.8
Carbohydrate (% en) 57.3 6 7.2
Fat (% en) 26.9 6 6.2
BP, blood pressure; TAG, triacylglycerol; NEFA, non-esterified fatty
acids.
Mean values 6 SD.
*Ethnicity: Malay n 5 47.
†Determined from 3-day weighed diet record using Nutritionist Pro
software (AXXYA Systems LLC., TX, USA).
‡Classification of overweight (BMI, 23–24.9 kg/m2) and obesity
(BMI $25 kg/m2) for Asian populations.
Chang et al Baseline characteristics of participants 1433were stratified according to menstrual cycle. Fasting blood
samples were collected at baseline, week 5, and week 6 of
each dietary intervention and mean values on treatment
were estimated. After the fasting blood sample at week 6,
an isocaloric (w880 kcal) test challenge meal of echoing
macronutrient composition to the background diet was
consumedwithin 15minutes, and postprandial blood samples
were collected. The primary outcome was a postprandial
change from fasting value in C-peptide, and secondary out-
comes were postprandial changes in glucose, NEFA, and
gut peptides (GLP-1, GIP, ghrelin, PYY, and CCK). All other
outcomes were exploratory. Compliance to the intervention
wasmonitored by changes in blood lipids. Power calculationswere based on a mean differential postprandial increment of
C-peptide from baseline concentration of 302.46 IU with a
significance level (alpha) of 0.05 (two-tailed), which gave
90%power to detect a difference in 44 subjects. This estimate
is based on a mean plasma C-peptide increment of 1049 IU
with awithin subject SD of 490 for a healthy, adult population
from our unpublished data.
Formulation of the test diets
Experimental diets were designed based on the mean
calorie requirement of participants based on a 3-day dietary
record before study commencement analyzed with Nutri-
tionist Pro software (AXXYA Systems LLC., Stafford, TX).
The test diets provided w2000 kcal/d with 14% en protein
standardized across diets and contained similar proportions of
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Figure 2 Study design. (A) Outline of diet intervention. (B) Randomized diet allocation.
1434 Journal of Clinical Lipidology, Vol 10, No 6, December 2016polyunsaturated fatty acids (Table 2). The basal diets supplied
22 g fat towhich 49 g oil was added on the SAFA (palm olein)
and MUFA (high oleic sunflower oil blend) diets and 34 g
(high-oleic sunflower oil blend) on the CARB with anTable 2 Composition of experimental diets
Variables SAFA diet
Total calorie (kcal/d) 2054.9 6 205.7
Total calorie (MJ/d) 8.6 6 0.9
Protein (% en) 13.8 6 2.2
Carbohydrate (% en) 54.7 6 4.7
Dietary sugar (g)* 63.2 6 15.3
Fat (% en) 31.5 6 4.3
SAFA (% en) 12.0 6 0.4
MUFA (% en) 13.1 6 0.3
PUFA (% en) 6.4 6 0.6
Dietary fiber (g)* 11.3 6 3.7
en, energy; SAFA, saturated fatty acids; CARB, carbohydrate; MUFA, monou
Mean values 6 SD. Duplicates of the meals were collected for total fat (So
*Calculated using Nutritionist Pro software (AXXYA Systems LLC. TX, USA).additional 28 g of simple sugar supplied as sweetened drinks.
All 3 main meals and snacks during the weekdays were pre-
pared by a trained caterer according to trial specifications.
Test oils were provided for weekend home meal preparation.CARB diet MUFA diet
2081.2 6 198.1 2054.9 6 205.7
8.7 6 0.8 8.6 6 0.9
14.3 6 2.3 13.8 6 2.2
61.4 6 3.8 54.7 6 4.7
91.3 6 25.7 63.2 6 15.3
24.3 6 2.7 31.5 6 4.3
4.5 6 0.5 5.0 6 0.8
14.0 6 0.5 20.5 6 1.0
5.8 6 0.5 6.0 6 0.5
12.8 6 3.7 11.3 6 3.7
nsaturated fatty acids; PUFA, polyunsaturated fatty acids.
xhlet method) and protein content (Kjeldahl method).
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trient composition calculated using Nutritionist Pro software
(AXXYA Systems LLC., Stafford, TX, USA). Test cooking,
laboratorymacronutrient analyses, and fatty acid composition
analyses were conducted to ascertain the desired nutrient pro-
file as reported in our previous study.17 The typical test diets
consisted of a serving of white rice, fish or chicken, fruit,
and drink; and two servings of vegetable (example of a
menu day refer to Supplemental Table 1). Sweetened barley,
honey, or rose syrup drinks (mean glycemic index (GI),
35.5 and glycemic load, 21.6)18 were provided alternately to
achieve desired medium GI content in the CARB diet, which
is representative of the typical South East Asian menu. Addi-
tional energy requirements were adjusted on an individual ba-
sis using snacks (pancake and cupcake) prepared with
macronutrient composition similar to the respective back-
ground dietary treatments.
Isocaloric mixed meal challenge
Subjects were provided low-fat chicken-flavored instant
cup porridge (Natures Own, Malaysia) as dinner the night
before the isocaloric mixed meal challenge. A cannula was
inserted into the antecubital vein of the subject’s forearm, 2
baseline fasting blood samples were then collected at 25
and 0 minutes. Subjects were provided isocaloric mixed
meals (a muffin with a glass of 250 mL strawberry-flavored
milkshake) providing w880 kcal with 16 g protein. The
high-fat (for both SAFA and MUFA) challenge meals
provided 51 g fat and 88 g carbohydrate; whereas the
low-fat/high-carbohydrate meal (CARB) provided 21 g fat
and 158 g carbohydrate. The additional carbohydrate in
CARB muffin and milkshake was supplied by Valens
Carborie glucose polymers module (Pharm-D, USA).
Blood samples were collected at baseline (in duplicate),
15, 30 minutes, and hourly till the 6 hour time-point.
Subject compliance
To ensure strict dietary compliance, subjects who failed
to collect .10% meals during each 6-week intervention
were considered drop-outs. Subjects were weighed bi-
weekly, and percentage body fat was assessed using a
body composition analyzer (TANITA). Dietary advice was
given to those who experienced .2 kg weight fluctuation.
The acceptability and palatability of the three diets were
evaluated using visual analog scales. Plasma and erythro-
cyte membrane lipid extract were collected at the end of
each dietary intervention phase for the analysis of fatty acid
composition. Fasting serum triacylglycerol and total, LDL,
and HDL cholesterol concentrations were also measured
after the completion of each dietary phase.
Biochemical analysis and lipid assay
All blood samples were collected by standard veni-
puncture procedures and drawn into blood collectiontubes (VACUETTE, Greiner Bio-One, Germany) con-
taining the corresponding additives. EDTA vacutainers
for high-sensitivity GLP-1 and total GIP were added with
dipeptidyl peptidase-IV inhibitor (Millipore Corporation,
UK). EDTA vacutainers for total ghrelin, total PYY,
and CCK were added with 4-(2-aminoethyl) benzenesul-
fonyl fluoride hydrochloride (R&D Systems, USA).
Packed erythrocyte where plasma was removed after
centrifugation was stored at 4C for 3 to 5 days before
treatment according to method specified in Rose and
Ocklander.19 All samples were kept frozen at 280C un-
til analysis.
Fatty acid composition of test oils, fat extracted from
diets, plasma, and erythrocyte membrane lipid extract was
analyzed by gas chromatography on a BPX 70 column
(30 m! 0.25 mm; SGE Sarl, Courtabœuf, France). Serum
C-peptide, insulin, Fructosamine, lipid, and plasma glucose
samples were analyzed by an accredited pathology labora-
tory (Pathlab & Clinical Laboratory (M) Sdn Bhd). The
analyses were performed with conventional methods using
Siemens Advia 2400 chemistry analyzer (Siemens Health-
care Diagnostics Inc.).
Calculations
HOMA2-IR and insulin sensitivity (HOMA2-%S) were
calculated based on fasting insulin and glucose concentra-
tions, whereas b-cell function (HOMA2-%B) was derived
from fasting C-peptide and glucose concentrations by using
the HOMA calculator, version 2.2.2 (http://www.dtu.ox.ac.
uk/homacalculator/, accessed June 2014). RQUICKI was
calculated as 1/(log fasting insulin (mU/mL) 1 log fasting
glucose (mg/dL) 1 log fasting NEFA (mmol/L)).20 Incre-
mental AUCs (iAUCs) were calculated by the conventional
trapezoid rule after the subtraction of baseline reading.
Insulin response corrected for glucose was defined as
iAUCinsulin/glucose (0–120 min). Disposition index (DI) was
calculated by multiplying insulin response corrected for
glucose with HOMA2-%S.
Statistical analysis
SPSS software (version 18; SPSS Inc, Chicago, IL) was
used for statistical analysis. Standard distributional checks
were made, logarithmic and square root transformations
were performed to normalize data, and the transformed
data were presented as geometric mean or else as mean.
Data were analyzed using one-way repeated measure
ANOVA, with time and meal as within-subject factors
and gender as a between-subject factor. Comparisons
between treatments were made using Bonferroni post
hoc test. The iAUCs were calculated using GraphPad
Prism software (version 5.02; Graph Pad software, Inc., La
Jolla, CA). Results were reported as mean/geometric
mean 6 SEM for fasting measurements after diet inter-
vention or geometric mean (95% CI) for measurements
during postprandial challenge.
Table 3 Fasting and postprandial metabolic parameters after following SAFA-diet, CARB-diet, and MUFA-diet interventions for 6
weeks
Variables SAFA diet CARB diet MUFA diet
Glucose metabolism
C-peptide (nmol/L)* 0.59 6 0.03 0.60 6 0.04 0.60 6 0.04
Insulin (mU/L) 14.99 6 1.26 14.74 6 1.15 15.12 6 1.43
Glucose (mmol/L) 5.80 6 0.85 5.77 6 0.84 5.76 6 0.84
NEFA (mmol/L)* 0.68 6 0.02 0.68 6 0.02 0.69 6 0.02
Fructosamine
(mmol/L)
304.1 6 3.80 309.8 6 4.90 313.3 6 5.10
RQUICKI 0.15 6 0.00 0.15 6 0.00 0.15 6 0.00
HOMA2-%B 100.49 6 14.66 98.96 6 14.43 100.36 6 14.64
HOMA2-%S 75.72 6 11.05 77.76 6 11.34 76.28 6 11.13
HOMA2-IR 1.72 6 0.25 1.70 6 0.25 1.74 6 0.25
Disposition index† 5605 6 806.4 4133 6 332.3 4942 6 413.4
Corrected insulin to
glucose ratio†,{
1.80 6 0.04 1.73 6 0.04 1.80 6 0.03
Gastrointestinal peptides release
GLP-1 (pM) 0.95 6 0.15 1.05 6 0.21 1.15 6 0.17
GIP (pg/mL) 45.83 6 4.04 42.05 6 3.77‡ 51.28 6 4.51
Ghrelin (pg/mL) 278.89 6 22.35 280.09 6 23.85 279.32 6 26.43
PYY (pg/mL)* 73.45 6 4.69 64.85 6 4.08 74.50 6 4.93
CCK (ng/mL)* 0.13 6 0.01 0.13 6 0.01 0.13 6 0.01
Lipids profile
Total cholesterol
(mmol/L)*
4.89 6 0.73‡ 4.79 6 0.72 4.71 6 0.82
LDL cholesterol
(mmol/L)*
3.05 6 0.56‡ 3.00 6 0.58 2.89 6 0.64
HDL cholesterol
(mmol/L)*
1.23 6 0.22x 1.18 6 0.21 1.21 6 0.84
Total: HDL
cholesterol*
4.06 6 0.77 4.13 6 0.79 4.01 6 0.85
Apo-B100 (g/L)* 0.91 6 0.18 0.91 6 0.18 0.90 6 0.18
Apo-A1 (g/L)* 1.27 6 0.16 1.25 6 0.14 1.25 6 0.19
Apo-B100: Apo-A1* 0.72 6 0.15 0.74 6 0.18 0.72 6 0.18
Lp(a) (mg/dL) 16.9 6 11.5 17.9 6 13.5 17.4 6 11.4
TAG (mmol/L) 1.31 6 0.73 1.30 6 0.62 1.29 6 0.73
SAFA, saturated fatty acids; CARB, carbohydrate; MUFA, monounsaturated fatty acids; NEFA, non-esterified fatty acids; RQUCIKI, revised Quantitative
Insulin Sensitivity Check Index; HOMA2-%b, homeostatic model assessment 2–pancreatic beta cell function; HOMA2-%S, homeostatic model assessment
2–insulin sensitivity; HOMA2-IR, homeostatic model assessment 2–insulin resistance; GLP-1, glucagon-like peptide-1; GIP, glucose-dependent
insulinotropic peptide; PYY, peptide YY; CCK, cholecystokinin; apo-B100, apolipoprotein-B100; apo-A1, apolipoprotein-A1; lp(a), lipoprotein (a);
TAG, triacylglycerol.
Values are means 6 SEM (*) or else geometric means 6 SEM for normalized data. n 5 47 (women n 5 35; men n 5 12), measured at fasting state.
†n5 46 (women n 5 34; men n5 12), measured during postprandial challenge. Data were analyzed by repeated measures ANOVA among three diets.
No significant difference between diets except where noted.
‡Significantly different compared with MUFA diet, P , .05.
xSignificantly different compared with CARB diet, P , .05.
{Repeated measure ANOVA, P , .05; Bonferroni’s Multiple Comparison Test, P . .05.
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Of 54 abdominally overweight participants randomized
into the three dietary interventions, 7 subjects withdrew,
and 1 subject was unwilling to participate in the mixed
meal postprandial challenge. Data were available for the
postprandial measures on 46 participants and 47 for fasting
measures. Their details are shown in Table 1. Waist circum-
ference was .80 cm in women and 90 cm for men, theparticipants showed elevated fasting insulin concentration,
which was approximately twice the value reported in non-
obese Malaysian subjects.17 Mean age, BMI, waist circum-
ference, fasting plasma glucose, and HOMA2-%S were
32.8 6 8.7 years, 28.7 6 4.1 kg/m2, 94.8 6 10.2 cm,
5.8 6 0.8 mmol/L, and 70.8 6 34.8, respectively. Of the
47 participants who completed the study, 59.6% had prior
undiagnosed impaired fasting glucose levels (5.6–
6.9 mmol/L), and 6.4% had previously undiagnosed
Chang et al Baseline characteristics of participants 1437diabetes ($7.0 mmol/L) based on ADA criteria21; 40.4%
had blood pressure .130/85 mm Hg; 38.3% had LDL
cholesterol .3.4 mmol/L.
Compliance
Subjects’ body weight (74.2 6 14.6 kg) remained
constant throughout study intervention. Compliance to the
SAFA, CARB, and MUFA diets was good with achieved
meal attendance of 97.1 6 4.4%, 98.0 6 3.2%, and
97.1 6 5.1%, respectively. Meal acceptability ratings of
7.0 6 1.2, 7.1 6 1.3, 6.9 6 1.4 and palatability ratings of
7.26 1.3, 7.36 1.3, 7.16 1.4 indicated that the three diets
were equally well-accepted. Changes observed in plasma
fatty acid composition between diets confirmed good
dietary compliance. SAFA diet (26.8 6 2.3%) had higher
plasma palmitic acid levels compared with CARB
(26.3 6 1.8%) and MUFA diets (26.0 6 2.0%), respec-
tively (P , .05); whereas SAFA diet (22.8 6 3.0%) ex-
hibited lower oleic acid content compared with both
CARB (24.7 6 2.7%) and MUFA (25.0 6 3.3%) diets
(P , .05). Changes in lipid profile (Table 3) were in agree-
ment with those previously reported22 where both total and
LDL cholesterol concentrations were mildly increased
(3.8%–5.5%) after SAFA diet compared with MUFA diet
(4.89 6 0.73 vs 4.71 6 0.82 mmol/L; 3.05 6 0.56 vs
2.896 0.64 mmol/L; P, .05). HDL cholesterol concentra-
tions were 4.2% higher after SAFA diet compared with
CARB diet (1.23 6 0.22 vs 1.18 6 0.21 mmol/L;
P , .05). No significant differences were observed between
diets in terms of effect on total:HDL cholesterol ratio, apo-
B100, apo-A1, lipoprotein (a), and triacylglycerol.
Postprandial C-peptide, insulin, glucose, and
NEFA responses
The primary outcome, postprandial changes in C-pep-
tide in response to the isocaloric challenge meal after
6 weeks of dietary intervention were found to express a
significant meal ! time ! gender interaction (P 5 .007)
after all meals (Supplemental Fig. 1). Women showed a de-
layed postprandial C-peptide increase at 2 hours but sus-
tained a higher level after 2 hours compared with men.
Plasma C-peptide was found to peak at 2.15 (1.92–2.37)
nmol/L (at 60 minutes), 3.61 (3.14–4.09) nmol/L (at
120 minutes), 2.28 (1.95–2.61) nmol/L (at 120 minutes)
for the SAFA, CARB, and MUFA meals, respectively.
With all 3 meals, C-peptide levels returned to baseline at
6 hours (P , .001; Fig. 3). The iAUCC-peptide (0-120 min)
were 77% and 72% higher after CARB meal compared
with SAFA and MUFA meals (P , .001). As expected, in-
sulin and glucose showed a significant meal ! time inter-
action (P 5 .000), with CARB meal displaying a higher
increase compared with SAFA and MUFA meals. Glucose
concentrations were found to peak at 30 minutes, and the
peak glucose after CARB meal was 25% higher compared
with both high-fat meals (9.29 [8.84–9.73] (CARB) vs 7.59[7.20–7.98] (SAFA), 7.44 [7.09–7.79] (MUFA) mmol/L).
The iAUC0–120 min of insulin, glucose, and NEFA after
CARB meal were 98%, 110%, and 28% higher compared
with SAFA meal and 86%, 107%, and 36% higher
compared with MUFA meal (P, .001 for all comparisons).
Insulin response corrected for glucose (P5 .048) but not DI
(P 5 .095) tended to be lower after the CARB meal
compared with the two high-fat meals (Table 3). There
was a significant meal ! time ! gender interaction
(P 5 .030) between meals for NEFA (Supplemental Fig. 1).
Postprandial gastrointestinal peptide release
The changes in gastrointestinal peptide concentrations
are depicted in Figure 3. There were significant changes
observed for GLP-1, GIP, and ghrelin after all meals
(meal! time interaction: P 5 .000). GLP-1 concentrations
were higher at 15 and 30 minutes but lower at 6 hours
(P , .05) after CARB meal compared with both high-fat
meals. GIP and ghrelin were found to express a significant
gender! time interactions (P , .05; Supplemental Fig. 1).
The pattern of increase of GLP-1 at 15 and 30 minutes was
mimicked by GIP, followed by a sharp decrease following
CARB at 4 and 6 hours compared with MUFA but not
SAFA meal (P , .05). Lower ghrelin level was detected
at 4 hours after CARB meal compared with high-fat meals
(P , .05). PYY showed a significant meal ! time interac-
tion (P 5 .000). No significant differences were detected
between all meals in CCK. The iAUC0–120 min for all
gastrointestinal peptides did not differ between meals.
Fasting insulin secretion, insulin sensitivity,
and gastrointestinal peptides
No significant differences were observed between the
impact of the 3 diets on fasting C-peptide, insulin, NEFA,
glucose, fructose, RQUICKI, HOMA2-%S, HOMA2-%B,
and HOMA2-IR after each 6-week dietary intervention
(Table 3). Fasting GIP concentrations were 18.0% lower
after CARB diet compared with MUFA diet (P , .05).
No appreciable differences between the 3 dietary interven-
tions were observed in fasting GLP-1, ghrelin, PYY, and
CCK.Discussion
The present study was designed to investigate both
fasting and postprandial effects of the replacement of SAFA
with carbohydrate or MUFA on insulin secretion and
sensitivity, glucose homeostasis, and gastrointestinal pep-
tide release in subjects with central obesity after a 6-week
isocaloric dietary intervention. As expected, the primary
outcome of the study as assessed by the postprandial
changes in the absolute C-peptide levels were higher after
a high-carbohydrate/low-fat mixed meal following a 6-
week background diet enriched with 7% en carbohydrate in
Figure 3 Postprandial C-peptide (A), insulin (B), glucose (C) and NEFA (D), GLP-1 (E), GIP (F), ghrelin (G), PYY (H), and CCK (I)
responses after SAFA (white circle, solid line), CARB (white triangle, solid line), or MUFA (white square, dotted line) meals. n 5 46 (34
women, 12 men). Change from preprandial value was significantly different for *CARB vs SAFA and MUFA meals (P , .05) and FCARB
vs MUFA meals (P , .05). Insert: iAUC over 120 min (A–C and E–I) and 360 min (D). White bars, SAFA; black bars, CARB; striped bars,
MUFA. siAUC was significantly higher compared with SAFA and MUFA meals, P , .001 (A–D).
1438 Journal of Clinical Lipidology, Vol 10, No 6, December 2016replacement of SAFA and MUFA. Despite the exaggerated
increase in plasma insulin after CARB meal, peak plasma
glucose was found to be 19% higher after CARB meal than
the normal glycemic response after the meal for healthy
subjects (,7.8 mmol/L) as defined by the International
Diabetes Federation.20 Furthermore, our study noted a de-
layed insulin peak at 2 hours in the South East Asian sub-
jects compared with data obtained from the Caucasians
where insulin peaked at 30 minutes,23 which indicated
impaired insulin sensitivity in this population.24 We can
perhaps infer therefore that the habitual diet consumed by
South East Asian populations, which consists of around
60% en carbohydrate with the majority comprised refined
carbohydrate, predisposes the population to higher inci-
dence of type 2 diabetes mellitus.25 The present study
also found that the postprandial insulin response correctedfor glucose after CARB meal tended to be lower compared
with both high-fat meals. The amount of carbohydrate
administered (158 g) represents the amount of carbohydrate
in a typical set meal in South East Asia, that is, pasta or
fried rice with a sweetened drink. Hence, our findings
imply that if an increase as little as 7% en on moderate
GI-refined carbohydrate (within a short period of 6 weeks)
in centrally obese subjects can attenuate insulin response
corrected for glucose, repetitive exposure to insulin hyper-
secretion may lead to the early exhaustion and apoptosis of
b cells and hence the increased risk of developing type 2
diabetes.26,27 On the other hand, our present study found
that the NEFA suppression following a high-carbohydrate
meal is greater compared with both high-fat meals as
greater insulin secretion in response to carbohydrate in-
hibits lipolysis. In line with our findings, other studies
Chang et al Baseline characteristics of participants 1439have demonstrated that the higher carbohydrate:fat ratio al-
leviates postprandial NEFA concentrations,28,29 which
could be explained by the NEFA-suppressing effect of insu-
lin overriding NEFA spillover as a consequence of high-fat
intake.30 The suppression of NEFA by a high-carbohydrate
meal promotes the storage of body fat.
Our study also demonstrated that the quality and
quantity of fats at 7% en exchange did not alter fasting
insulin secretion and sensitivity as measured by HOMA2-%
S or glucose homeostasis after a 6-week isocaloric dietary
intervention in abdominal overweight individuals. In accor-
dance to the findings of our previous study in healthy
subjects17 and 2 large scale studies in insulin resistant7 and
metabolic syndrome6 subjects, our results showed that diet
enrichment with SAFA is comparable with carbohydrate or
MUFA with regard to its effect on insulin sensitivity. Both
the RISCK7 and LIPGENE6 studies found that the substitu-
tion of SAFAwith carbohydrate and MUFA did not result in
significant differences in insulin sensitivity and acute insu-
lin response to glucose. Another large scale study, the
KANWU5 study however reported borderline significant
difference in treatment effect between SAFA and MUFA
(P 5 .053) where SAFA impaired insulin sensitivity
compared to baseline, whereas no appreciable difference
was detected in insulin secretion and first-phase insulin
response (acute insulin response to glucose was not
measured). The wide variation of total fat intake (29–45%
en) in the free-living subjects and the weaker baseline insu-
lin sensitivity in the SAFA group may have confounded the
finding of the parallel-designed KANWU study. Our study
avoided such limitation by setting each subject as his own
control using the crossover design and by providing cen-
trally prepared meals. Furthermore, we found DI was
similar after all diets, whereas none of the four mentioned
study made the measurement.
Our investigation on the concomitant changes of gastro-
intesinal peptides is not prominent in most other studies.
We observed a decrease in fasting GIP level after CARB
diet compared with MUFA diet. This observation is novel.
There is positive in vivo evidence that reduced fasting GIP
concentrations are associated with improved insulin sensi-
tivity31,32; our findings however did not concur with this
observation. The contradiction may suggest that the
reduced fasting GIP concentrations as observed after a 6-
week CARB diet may not be related to the intrapancreatic
actions. This may be explained by the observations of two
short-term feeding intervention studies, which reported that
high-fat overfeeding increased fasting GIP concentra-
tions33,34 possibly due to fat deposition. It was reported
that GIP binds to its receptor on adipose tissue and in-
creases the adipose tissue volume.35 The reduced fasting
GIP levels as observed in CARB diet group may indicate
lesser fat deposition, which needs further confirmation.31
However, we did not observe significant changes in %
body fat between diets as measured by body composition
analyzer. No different changes were detected on fasting
GLP-1, ghrelin, PYY, and CCK concentrations irrespectiveof dietary alterations in fat quality or fat quantity as re-
ported by others.35–40
Our study showed no appreciable differences between
meals in the postprandial gastrointestinal peptide responses
as indicated by iAUC0–120 min. The spikes of GLP-1 and
GIP at the early phase occurred in response to the notice-
ably elevated glucose level after CARB meal, which stim-
ulated insulin secretion and inhibit glucagon secretion.
High-fat meal has been found to create greater rise in
GLP-1 and PYY than high-carbohydrate meal over the 3-
hour measurement in healthy adults,41,42 we however did
not observe such difference. The impaired GLP-1 and
PYY responses after high-fat load may be due to insulin
resistance and impaired glucose homeostasis in our obese
subjects.43 Studies have reported that in healthy subjects,
carbohydrate results in greater postprandial ghrelin sup-
pression in the first 3 hours than fat.44 However, blunted
ghrelin suppression by carbohydrate was demonstrated in
our abdominally overweight subjects. This is pursuant to
the finding that postprandial ghrelin response is indepen-
dent of macronutrient composition in obese subjects.42,45
Some studies reported that high-fat intake induces higher
PYY and CCK responses compared with high carbohy-
drate42,46 but not all.39,41 In line with two other acute
studies comparing high-fat and high-carbohydrate meals
between lean and obese men,47,48 we found that alterations
in fat quantity had similar impact on postprandial PYY and
CCK in our obese subjects. The lipid-sensing action of
PYY and CCK appeared to be less sensitive in overweight
or obese subjects. All together, the differential effects of fat
quality and fat quantity on gastrointestinal peptides were
not seen in our subjects with abdominal obesity with major-
ity of them having impaired fasting glucose and insulin
resistance. Because the release of gastrointestinal peptides
is controlled by neuronal and humoral interaction between
the brain and gut, the impaired gastrointestinal peptide
secretion may reflect brain-gut miscommunication in this
group of population.49 The disregulation could cause
over-feeding and dis-inhibition of liver glucose production
and thus facilitate the development of obesity and meta-
bolic disturbances.49
The present study has limitations. As the study subjects
were abdominally overweight with the majority having
insulin resistance and undiagnosed dysglycemia before
enrollment, the findings from this study may not be general-
ized to all other populations. The subjects were of South East
Asian origin; hence, they represented a high-risk population,
which are susceptible to the development of diabetes
mellitus.50 There are several strengths of the study. First,
this study design incorporated a controlled dietary interven-
tion under free-living conditions that reflects South EastAsian
diets. Second, we achieved good compliance with the dietary
intervention that resulted in expected changes in lipid profile
and plasma fatty acid composition, as well as a constant sub-
ject bodyweight across all 3 diets for the entire study duration.
The changes in insulin secretion and sensitivity were
measured at physiological levels, which reflected real life
1440 Journal of Clinical Lipidology, Vol 10, No 6, December 2016scenarios. Lastly, unlikemany studieswe also calculated insu-
lin response corrected for glucose and DI, which are more
valid measures of insulin secretion.
In conclusion, a 7% en exchange of carbohydrate with
SAFA impaired insulin secretion corrected for glucose but
had no effect on insulin sensitivity, glucose homeostasis,
and gastrointestinal peptide concentrations in abdominally
overweight individuals after a 6-week isocaloric dietary
intervention. As expected, high-carbohydrate meal
increased insulin and glucose secretions, which may be
detrimental to b-cell function in the long run as evidenced
by the reduced insulin secretion corrected for glucose ratio.
The type of fat, that is, SAFA and MUFA, however did not
exert differential impact on glucose homeostasis, insulin
sensitivity, insulin secretion, and gastrointestinal peptide
release under fasting and postprandial conditions.Acknowledgments
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Supplemental Table 1 Sample menu following SAFA, CARB,
and MUFA diets
Sample menu
Breakfast
Pancake
Potato (cooked in curry)
Corn pudding
Watermelon
Cocoa drink
Lunch
White rice
Torpedo scad fish cooked with sambal
Stir-fried mixed vegetables
Lettuce
Honeydew melon
Tea
Dinner
White rice
Oyster-sauced chicken drumstick
Stir-fried Chinese chives
Oyster mushroom and mixed vegetables
Pear
Sweetened barley drink*
*Provided for CARB diet only.
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